Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Kishore V. Seendripu, Ph.D. MXL Maxlinear, Inc 13G/A 6.6% 2y
MSD Partners, L.P. ARKO ARKO Corp. 13G/A 6.8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ MNDY monday.com Ltd. 13G 6.6% 2y
BAKER BROS. ADVISORS LP CERS Cerus Corp 13G/A 10.8% 2y
PUBLIC INVESTMENT FUND LYV Live Nation Entertainment, Inc. 13G/A 5.5% 2y
Prof. Ugur Sahin, M.D. BNTX BioNTech SE 13G/A 17.4% 2y
BIOTECHNOLOGY VALUE FUND L P MTEM Molecular Templates, Inc. 13G/A 9.99% 2y
Redmile Group, LLC ADXS Advaxis, Inc. 13G/A 1.9% 2y
METEORA CAPITAL, LLC OKLO Oklo Inc. 13G 7.59% 2y
BIOTECHNOLOGY VALUE FUND L P CTMX CytomX Therapeutics, Inc. 13G/A 9.99% 2y
PRICE T ROWE ASSOCIATES INC /MD/ DT Dynatrace, Inc. 13G 7.4% 2y
Edison Partners Management, LLC GRSD GRANDSTAND Ltd 13G/A 7.59% 2y
Deep Track Capital, LP HLVX HilleVax, Inc. Common Stock 13G/A 5.99% 2y
David Kirn FDMT 4D Molecular Therapeutics, Inc. 13G/A 4.7% 2y
PRICE T ROWE ASSOCIATES INC /MD/ OBIO Orchestra BioMed Holdings, Inc. 13G 1.7% 2y
ALLIANCEBERNSTEIN L.P. HAIN Hain Celestial Group Inc 13G/A 7.5% 2y
Nantahala Capital Management, LLC LXFR Luxfer Holdings PLC 13G/A 6.7% 2y
Vellar Opportunities Fund Master, Ltd. SHFS SHF Holdings, Inc. 13G/A 2.08% 2y
Aristotle Capital Management, LLC ELS Equity Lifestyle Properties Inc 13G 5.95% 2y
PRICE T ROWE ASSOCIATES INC /MD/ RL Ralph Lauren Corp 13G 5.7% 2y
RTW INVESTMENTS, LP SYRE Spyre Therapeutics, Inc. 13G 6.2% 2y
NOMURA HOLDINGS INC ETWO E2open Parent Holdings, Inc. 13G 5.3% 2y
Altai Capital Management, L.P. SKYH Sky Harbour Group Corp 13G/A 36.8% 2y
BIOTECHNOLOGY VALUE FUND L P RNTX Rein Therapeutics, Inc. 13G/A 0% 2y
Walleye Capital LLC CXAI CXApp Inc. 13G 5.33% 2y
ARMISTICE CAPITAL, LLC GLBS Globus Maritime Ltd 13G/A 5.51% 2y
PURA VIDA INVESTMENTS, LLC QTRX Quanterix Corp 13G/A 2.14% 2y
Repertoire Partners LP BCIC BCP Investment Corp 13G/A 7.1% 2y
ALLIANCEBERNSTEIN L.P. CVLT Commvault Systems Inc 13G/A 3% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC DTF Dtf Tax-Free Income 2028 Term Fund Inc 13G 6.13% 2y
Walleye Capital LLC GNLN Greenlane Holdings, Inc. 13G/A 0% 2y
Avoro Capital Advisors LLC BCRX Biocryst Pharmaceuticals Inc 13G 6.4% 2y
Caledonia (Private) Investments Pty Ltd FXLV F45 Training Holdings Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. ATRI Atrion Corp 13G 6.6% 2y
T. Rowe Price Investment Management, Inc. FBK FB Financial Corp 13G/A 10.1% 2y
T. Rowe Price Investment Management, Inc. IDA Idacorp Inc 13G 5.5% 2y
First Trust Capital Management L.P. GLAC Global Lights Acquisition Corp Ordinary Shares 13G 6.38% 2y
Access Industries Management, LLC ZURA Zura Bio Ltd 13G/A 9.9% 2y
T. Rowe Price Investment Management, Inc. CAL Caleres Inc 13G 12.7% 2y
Vellar Opportunities Fund Master, Ltd. OIO OIO Group 13G/A 9.99% 2y
Park West Asset Management LLC LNSR LENSAR, Inc. 13G/A 9.9% 2y
First Euro Investments Limited MMV MultiMetaVerse Holdings Limited Class A Ordinary Share 13G 5.3% 2y
Omega Fund VI, L.P. IMA ImageneBio, Inc. 13G/A 4.7% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SEM Select Medical Holdings Corp 13G/A 13.3% 2y
Joseph DaGrosa, Jr. JETMF Global Crossing Airlines Group Inc. 13G/A 4.3% 2y
T. Rowe Price Investment Management, Inc. TXT Textron Inc 13G/A 6.9% 2y
Charles Liang SMCI Super Micro Computer, Inc. 13G/A 13.9% 2y
VIKING GLOBAL INVESTORS LP PEPG PepGen Inc. 13G/A 6.2% 2y
ARMISTICE CAPITAL, LLC PTIX Protagenic Therapeutics, Inc.new 13G/A 5.13% 2y
T. Rowe Price Investment Management, Inc. IONS Ionis Pharmaceuticals Inc 13G 9.2% 2y